These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8385747)

  • 1. The actions of the kappa 1 opioid agonist U-50,488 on presynaptic nerve terminals of the chick ciliary ganglion.
    Fletcher GH; Chiappinelli VA
    Neuroscience; 1993 Mar; 53(1):239-50. PubMed ID: 8385747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous miniature hyperpolarizations of presynaptic nerve terminals in the chick ciliary ganglion.
    Fletcher GH; Chiappinelli VA
    Brain Res; 1992 May; 579(1):165-8. PubMed ID: 1623403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inward rectifier is present in presynaptic nerve terminals in the chick ciliary ganglion.
    Fletcher GH; Chiappinelli VA
    Brain Res; 1992 Mar; 575(1):103-12. PubMed ID: 1324081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes.
    Rawls SM; McGinty JF; Terrian DM
    J Neurochem; 1999 Sep; 73(3):1058-65. PubMed ID: 10461895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.
    Inenaga K; Nagatomo T; Nakao K; Yanaihara N; Yamashita H
    Neuroscience; 1994 Jan; 58(2):331-40. PubMed ID: 7908725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonopioid actions of the kappa-opioid receptor agonists, U 50488H and U 69593 on electrophysiologic properties of hippocampal CA3 neurons in vitro.
    Alzheimer C; ten Bruggencate G
    J Pharmacol Exp Ther; 1990 Nov; 255(2):900-5. PubMed ID: 1978733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
    Pinnock RD
    Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
    Müller W; Hallermann S; Swandulla D
    J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
    Shen KF; Crain SM
    Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.
    Proietti ML; Scotti de Carolis A; Frank C; Zeng YC; Sagratella S
    Neuropharmacology; 1991 Jun; 30(6):637-42. PubMed ID: 1656303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro.
    Chieng B; Christie MJ
    Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals.
    Gannon RL; Terrian DM
    Brain Res; 1991 May; 548(1-2):242-7. PubMed ID: 1678297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.
    Ventura C; Capogrossi MC; Spurgeon HA; Lakatta EG
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1671-4. PubMed ID: 1659231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release.
    Simmons ML; Chavkin C
    Mol Pharmacol; 1996 Jul; 50(1):80-5. PubMed ID: 8700123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    Kapusta DR; Obih JC
    J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
    Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
    Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro.
    McFadzean I; Lacey MG; Hill RG; Henderson G
    Neuroscience; 1987 Jan; 20(1):231-9. PubMed ID: 3031541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.